JointMedica, a global leader in orthopedic innovation, announces the commencement of an Investigational Device Exemption (IDE) study for its Polymotion® Hip Resurfacing (PHR®) device. The IDE study aims to evaluate the safety and clinical effectiveness of the Polymotion® Hip Resurfacing System to address the challenges faced by younger, more active patients.
Investigational Device Exemption (IDE) study
-
Schoeneman Building, 5th Floor
2401 W. Belvedere Avenue
Baltimore, MD 21215 -
10084 Reisterstown Road,
Suite 300-A
Owings Mills, MD 21117 -
Orthopedic Suite, Main Floor
5401 Old Court Road
Randallstown, MD 21133